A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
Clinical trial NCT01774786 · COMPLETED
Trial details
- NCT number
- NCT01774786
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-10
- Primary completion
- 2016-12-09
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.